Dr. Alexander Bilbily, a radiologist and affiliate scientist at Sunnybrook, has been awarded the inaugural Sunnybrook Innovation and Impact Award. This accolade recognizes his development of the AI screening tool, Rho, which automatically screens patient X-ray scans for low bone mineral density (BMD) and alerts physicians of increased risk of osteoporosis. Rho has received regulatory approval in Canada, the United States, Australia, and Singapore, and has been instrumental in screening over 400,000 Canadians. Dr. Bilbily is also the co-founder and co-CEO of 16-Bit, an AI-based medical device company, and serves as the director of the Augmented Precision Medicine Lab at Sunnybrook, where he furthers healthcare innovation through AI-based diagnostic and screening tools for medical imaging. His efforts are vital in educating healthcare professionals and mentoring the next generation of innovators in AI healthcare applications.<\/p>\n","protected":false},"excerpt":{"rendered":"
Dr. Alexander Bilbily, a radiologist and affiliate scientist at Sunnybrook, has been awarded the inaugural Sunnybrook Innovation and Impact Award. This accolade recognizes his development of the AI screening tool,…<\/p>\n","protected":false},"author":1,"featured_media":951,"comment_status":"","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1586],"tags":[1084,3075,2011,12252,551],"class_list":["post-13229","post","type-post","status-publish","format-standard","has-post-thumbnail","category-toronto","tag-ai-healthcare","tag-medical-innovation","tag-ontario-founder-news","tag-osteoporosis-screening","tag-toronto-founder-news"],"acf":[],"yoast_head":"\n